Literature DB >> 32217053

Post pregnancy contraception.

Anita Makins1, Sharon Cameron2.   

Abstract

Ovulation resumes as quickly as 21 days after birth in a non-fully breastfeeding woman. Traditionally, contraceptive services have been offered 6 weeks post-partum. This is far from ideal and results in unnecessary abortions or inadequate birth spacing which both carry an increased risk of morbidity to mother and potential newborn as well as costs to the health care service. It is now clear that contraception should be discussed during the pregnancy so that the method of choice can be offered immediately post pregnancy prior to discharge from hospital. Long acting reversible contraceptive methods such as implants and IUDs are highly effective as they are user-independent. Large studies have demonstrated that they can be safely inserted during the immediate post-partum period with no increase in complication rates. Policy makers should strive to overcome barriers to offering quality post pregnancy contraceptive services.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Post pregnancy; Post-abortion contraception and family planning; Post-partum

Year:  2020        PMID: 32217053     DOI: 10.1016/j.bpobgyn.2020.01.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  4 in total

1.  Economic Evaluation of Provision of Postpartum Intrauterine Device Services in Bangladesh and Tanzania.

Authors:  Gillian Eva; Judy Gold; Anita Makins; Suzanna Bright; Katherine Dean; Emily-Anne Tunnacliffe; Parveen Fatima; Afroja Yesmin; Projestine Muganyizi; Grasiana F Kimario; Kim Dalziel
Journal:  Glob Health Sci Pract       Date:  2021-03-31

2.  Acceptability of ENG-releasing subdermal implants among postpartum Brazilian young women during the COVID-19 pandemic.

Authors:  Mariane Massaini Barbieri; Thuany Bento Herculano; Amanda Dantas Silva; Luis Bahamondes; Cassia Raquel Teatin Juliato; Fernanda Garanhani Surita
Journal:  Int J Gynaecol Obstet       Date:  2021-04-29       Impact factor: 4.447

3.  A non-inferiority analysis of hemoglobin levels in postpartum IUD users in Bangladesh.

Authors:  Suzanna Bright; Georgia R Gore-Langton; Parveen Fatima; Farhana Dewan; Afroja Yesmin; Anita Makins
Journal:  Int J Gynaecol Obstet       Date:  2022-03-06       Impact factor: 4.447

4.  The negative impact of COVID-19 on contraception and sexual and reproductive health: Could immediate postpartum LARCs be the solution?

Authors:  Anita Makins; Sabaratnam Arulkumaran
Journal:  Int J Gynaecol Obstet       Date:  2020-06-25       Impact factor: 4.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.